News
February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.
February 10, 2008
News
February 11, 2008 - Having a heart attack is apparently not sufficient reason for most people to change to a heart-healthy diet, a new study finds. "We found that diet quality is poor after a coronary heart disease event," said study author Yunsheng Ma, M.D., an assistant professor of medicine at the University of Massachusetts Medical School, in Worcester.
February 10, 2008
Technology
A third round of software enhancements has been made to the iLab System 1.3, an ultrasound imaging system designed to strengthen physician confidence in the diagnosis and intervention of percutaneous coronary intervention (PCI) and increase workflow efficiency.
February 10, 2008Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026News
February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.
February 10, 2008
Technology
GE's Innova BiPlane cardiovascular imaging system is one of the first digital flat panel biplane systems with a full ...
February 10, 2008News
February 11, 2008 - The first patient has enrolled in the PROENCY (PROMUS, Endeavor and Cypher) European registry ...
February 10, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026News
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 07, 2008Technology
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 07, 2008News
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 07, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
February 8, 2008 – CryoLife Inc. said it received FDA 510(k) clearance for its CryoValve SG pulmonary human heart valve ...
February 07, 2008Technology
Emageon's HeartSuite offers cardiovascular information management, hemodynamic monitoring, advanced visualization and content management. Emageon’s architecture combines HeartSuite with radiology and other medical specialties designed to offer a comprehensive patient–centric view of the visual medical record. One suite of integrated, enterprise cardiology tools includes:
February 07, 2008News
February 8, 2008 - Emageon received first place in the “Best in KLAS” Top 20 Report for the Cardiology PACS nomination ...
February 07, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...
February 07, 2008Technology
CryoLife Inc.'s CryoValve SG pulmonary human heart valve is processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 07, 2008News
February 6, 2008 - The Medical University of South Carolina (MUSC) opens the doors of Ashley River Tower, its new state-of-the-art hospital designed to treat patients with cardiovascular and digestive disease problems, marking the first step in the hospital’s multiphase expansion plan, which will ultimately replace the facility that for 50 years has served as the teaching hospital for MUSC.
February 06, 2008